IDEXX Laboratories, Inc.
IDXX
$491.70
$1.720.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.63% | -2.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.63% | -2.18% | |||
| Cost of Revenue | -2.24% | 1.09% | |||
| Gross Profit | 9.24% | -4.26% | |||
| SG&A Expenses | -1.38% | 42.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.55% | 13.51% | |||
| Operating Income | 20.96% | -28.38% | |||
| Income Before Tax | 20.94% | -14.23% | |||
| Income Tax Expenses | 67.52% | -39.10% | |||
| Earnings from Continuing Operations | 12.27% | -7.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.27% | -7.17% | |||
| EBIT | 20.96% | -28.38% | |||
| EBITDA | 18.69% | -26.06% | |||
| EPS Basic | 13.00% | -6.65% | |||
| Normalized Basic EPS | 21.73% | -28.47% | |||
| EPS Diluted | 12.99% | -6.44% | |||
| Normalized Diluted EPS | 21.86% | -28.42% | |||
| Average Basic Shares Outstanding | -0.64% | -0.56% | |||
| Average Diluted Shares Outstanding | -0.75% | -0.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||